A randomized, phase 3, double-blind trial examining methotrexate and etanercept as monotherapy or in combinstion for treating psoriatic arthritis: A comparison of the composite measures used to evaluate disease activity
Principais autores: | , , , , , , , , , |
---|---|
Formato: | Conference item |
Publicado em: |
BMJ Publishing Group
2019
|
Resumo: |
---|